IL6 and metabolic dysfunction-associated steatotic liver disease: It is known that abnormal amounts of liver fat in MASLD patients cause inflammation by invading immune cells and secreting cytokines, one of which is interleukin-6 (IL-6), a crucial immunomodulatory cytokine that influences the pathophysiology of MASLD [41].